Skip to main content

Table 8 Combined effects of rs7278, rs3734703 and rs1042919 genotypes on chemotherapy response in AML patients

From: Polymorphisms at microRNA binding sites of Ara-C and anthracyclines-metabolic pathway genes are associated with outcome of acute myeloid leukemia patients

Composite scorea

N

CR (%)

P

P b

OR (95% CI)b

0

32

68.8

  

1.00 (reference)

1

77

79.2

0.246

0.270

1.767 (0.642–4.865)

2

79

94.9

0.001

0.001

8.604 (2.318–31.93)

3

18

100

0.998

0.998

–

1 + 2 + 3

174

85.4

0.005

0.008

3.624 (1.398–9.395)

  1. aCombined genotype score model was created by compiling the genotyped data of SNPs rs7278, rs3734703 and rs1042919. Score 1 indicated favorable genotypes (i.e., rs7278 TT/TC genotype, rs3734703 CC/AA genotype, or rs1042919 TT genotype) and a score of 0 indicated unfavorable genotypes (i.e., rs7278 CC genotype, rs734693 CA genotype, or rs1042919 AA/AT genotype). After adding up these scores, four composite score groups were generated: composite score 0, 1, 2 and 3
  2. bAdjusted for age, risk stratifications and platelets